Treatment-resistant depression is unfortunately common and difficult to treat. It can interfere with your daily life and make even simple tasks feel impossible. The FDA-approval of SPRAVATO® (esketamine) for adults with treatment-resistant depression and major depressive disorder with suicidality has given many patients newfound hope. SPRAVATO® works differently from other antidepressants and can bring relief if other antidepressants have not worked for you.
SPRAVATO® acts through a different mechanism in the brain than common antidepressants used to treat depression. It can quickly improve your mood and help you better manage your symptoms. The treatment is delivered in a doctor’s office to ensure patient safety.
Depression often makes people feel like they are alone in this world. After trying many treatments that have not given the desired results, people may feel hopeless. However, there is hope. You may be eligible for SPRAVATO® if you:
During an initial consultation, our qualified and experienced professionals can review your medical history, assess your condition, discuss your needs and goals, and determine if SPRAVATO® is right for you.
SPRAVATO® treatment occurs in a clinical setting, where the patient receives treatment under close therapist monitoring. This means that a patient under SPRAVATO® treatment can expect to:
We will work closely with you to create a treatment plan that aligns with your unique needs and goals. At The Holiner Psychiatric Group, your safety and well-being are our top priority, so we are ready to answer any questions or concerns you may have.
If you are considering treatment for your treatment-resistant depression, SPRAVATO® may be a safe, viable option. To learn more about the FDA-approval of SPRAVATO® and how The Holiner Psychiatric Group offers individualized care for every patient, get in touch with us today to schedule a consultation.